Scorpius Holdings Files 8-K

TL;DR

SCPX filed an 8-K on 12/27/24, check for updates.

AI Summary

Scorpius Holdings, Inc. filed an 8-K on December 27, 2024, reporting other events and financial statements. The company, formerly known as NightHawk Biosciences, Inc. and HEAT BIOLOGICS, INC., is incorporated in Delaware and headquartered in Morrisville, North Carolina.

Why It Matters

This filing provides an update on Scorpius Holdings' corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, which typically reports significant corporate events or financial updates without immediate market-moving news.

Key Players & Entities

• Scorpius Holdings, Inc. (company) — Registrant
• NightHawk Biosciences, Inc. (company) — Former Company Name
• HEAT BIOLOGICS, INC. (company) — Former Company Name
• December 27, 2024 (date) — Date of Report

FAQ

Key Financial Figures

• $0.0002 — nge on which registered Common Stock, $0.0002 par value per share SCPX NYSE America
• $1.8 million — ort-term investments were approximately $1.8 million. To meet our financing needs, we are co

Filing Documents

• scpx_8k.htm (8-K) — 28KB
• 0001079973-24-001779.txt ( ) — 245KB
• scpx-20241227.xsd (EX-101.SCH) — 3KB
• scpx-20241227_def.xml (EX-101.DEF) — 29KB
• scpx-20241227_lab.xml (EX-101.LAB) — 36KB
• scpx-20241227_pre.xml (EX-101.PRE) — 26KB
• scpx_8k_htm.xml (XML) — 5KB

01. Other Events

Item 8.01. Other Events. Scorpius Holdings, Inc., a Delaware corporation (the "Company") is supplementing the Company's risk factors in its Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 26, 2024, and its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, filed with the SEC on November 14, 2024, with the risk factor set forth below. We will need additional future financing which may not be available on acceptable terms, if at all. We will need to raise additional capital in the next month to fund our operations and we cannot be certain that funding will be available to us on acceptable terms on a timely basis, or at all. As of December 20, 2024, our cash and cash equivalents and short-term investments were approximately $1.8 million. To meet our financing needs, we are considering multiple alternatives, including, but not limited to, additional equity financings, which we expect will include sales of common stock, debt financings, equipment sale leasebacks, and/or funding from partnerships or collaborations. Our ability to raise capital through the sale of securities may be limited by our inability to utilize a registration statement on Form S-3 to raise capital until June 2025 due to the late filing of our 2023 Annual Report and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, and due to various rules of NYSE American that place limits on the number and dollar amount of securities that we may sell. To the extent that we raise additional funds by issuing equity securities, our stockholders may experience significant dilution. Any debt financing, if available, may involve restrictive covenants that may impact our ability to conduct our business. If we fail to raise additional funds on acceptable terms, we may be unable to continue to maintain our listing on the NYSE American or allow us to continue operations. If we are unable to raise additional capital in sufficient amoun

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within in the inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 27, 2024 SCORPIUS HOLDINGS, INC. By: /s/ Jeffrey Wolf Name: Jeffrey Wolf Title: Chairman, President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR